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Abstract
Background: Genome sequencing of Leishmania species that give rise to a range of disease phenotypes in the host has
revealed highly conserved gene content and synteny across the genus. Only a small number of genes are differentially
distributed between the three species sequenced to date, L. major, L. infantum and L. braziliensis. It is not yet known how
many of these genes are expressed in the disease-promoting intracellular amastigotes of these species or whether genes
conserved between the species are differentially expressed in the host.
Methods/Principal Findings: We have used customised oligonucleotide microarrays to confirm that all of the differentially
distributed genes identified by genome comparisons are expressed in intracellular amastigotes, with only a few of these
subject to regulation at the RNA level. In the first large-scale study of gene expression in L. braziliensis, we show that only
,9% of the genes analysed are regulated in their RNA expression during the L. braziliensis life cycle, a figure consistent with
that observed in other Leishmania species. Comparing amastigote gene expression profiles between species confirms the
proposal that Leishmania transcriptomes undergo little regulation but also identifies conserved genes that are regulated
differently between species in the host. We have also investigated whether host immune competence influences parasite
gene expression, by comparing RNA expression profiles in L. major amastigotes derived from either wild-type (BALB/c) or
immunologically compromised (Rag2
2/2 cc
2/2) mice. While parasite dissemination from the site of infection is enhanced in
the Rag2
2/2 cc
2/2 genetic background, parasite RNA expression profiles are unperturbed.
Conclusion/Significance: These findings support the hypothesis that Leishmania amastigotes are pre-adapted for
intracellular survival and undergo little dynamic modulation of gene expression at the RNA level. Species-specific parasite
factors contributing to virulence and pathogenicity in the host may be limited to the products of a small number of
differentially distributed genes or the differential regulation of conserved genes, either of which are subject to translational
and/or post-translational controls.
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Introduction
Infection with species of the kinetoplastid parasite, Leishmania,
results in a spectrum of diseases in man, termed the leishmaniases
[1,2]. These range from the non-fatal chronic cutaneous lesions
arising from L. major infection to mucocutaneous leishmaniasis
usually associated with L. braziliensis (classified within the sub-genus
L. Viannia) and the often fatal visceralising disease, most commonly
associated with L. donovani infection in the Indian sub-continent, L.
chagasi in Brazil and L. infantum in the Mediterranean basin. (The
last two species are generally considered to be genetically identical
[3]). While the species of infecting parasite can play a defining role
in disease type, the genetic background and immune response of
the host are also major factors in determining clinical outcome
[4,5,6,7,8,9]. Understanding the relative contribution of these
different components may enhance our understanding of patho-
genicity in the leishmaniases.
Sequencing and comparison of the genomes of representative
lab-adapted strains of L. major, L. infantum and L. braziliensis have
revealed strong conservation of gene content and synteny, with
only a small number of genes identified as differentially distributed
between species [1,10]. This subset of genes, together with
sequences preferentially expressed in intracellular amastigotes
and/or showing differential expression between species, may be
important in facilitating parasite survival and maintenance within
the host. The best-characterised example of the former class is the
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protein of as yet unknown function which, when expressed in L.
major, leads to increased parasite dissemination to the viscera [11].
Recent expression profiling has identified 3–9% of genes that
are modulated at the RNA level between life cycle stages of several
Leishmania species [12,13,14,15]. Moreover, comparisons of L.
mexicana amastigote parasites grown axenically with those main-
tained within macrophages, either in vitro or in vivo, have shown
that axenic (extracellular) amastigotes are more similar to
extracellular promastigotes than to macrophage-derived (intracel-
lular) amastigotes in their RNA profiles [12]. These observations
emphasise the importance of using parasites isolated ex vivo to
investigate the mechanisms of intracellular survival. To date, no
comparative expression profiling has been performed on L. Viannia
spp., despite the relative divergence of the genome of L. braziliensis
from that of L. major or L. infantum [1].
A complicating factor intheanalysis ofLeishmaniagene expression
is the almost complete absence of defined RNA polymerase II
promotors in kinetoplastid species, coupled with the characteristic
bidirectional polycistronic transcription units found on individual
chromosomes [16,17,18]. In these organisms, polycistronic precur-
sor RNAs (which may be expressed constitutively) are processed by
coupled trans-splicing and polyadenylation [19] to generate mature
mRNA transcripts for translation. Expression of individual genes is
regulated post-transcriptionally, a process largely dependent on
RNA stabilisation mechanisms [17,18]. This post-transcriptional
regulation, coupled with an as yet unknown extent of regulation at
the level of translation, results in variable correlations between gene
and protein expression levels [20,21]. Such factors place greater
emphasis on identifying those genes which undergo regulation
during the life cycle while also looking for differences in the relative
levels of expression of conserved genes.
Given the importance of intracellular Leishmania stages to disease
in man, this study has focused on amastigote gene expression,
comparing RNA expression profiles between the three sequenced
Leishmania species to identify any significant differences that may
be functionally relevant in these infective parasite stages. To
achieve this end, an oligonucleotide array was designed represen-
tative of 4 functional classes of genes, together comprising ,10%
of the genome. These targets included (i) all genes identified as
differentially-distributed between the 3 sequenced Leishmania
species [1]; (ii) all genes containing amino acid repeats within
their open reading frames [22]; (iii) all genes encoding proteins
predicted (with high probability) to be co-translationally modified
by N-myristoylation [23]; (iv) a range of control genes of known
RNA expression profiles.
The rationale for this choice of target genes is that their expressed
products provide a subset for analysis as putative targets for
therapeutic intervention. 2–4% of the 3 sequenced Leishmania
genomes, including 30% of the differentially-distributed genes,
contain amino acid repeats within their protein-coding regions, as
identified by the RepSeq web utility [22]. Repeat domains are
associated witha range of functions relevant to hostsurvival in other
protozoanparasites, includingantigenic variation,host-cellreceptor
binding and intracellular protein-protein interactions in Plasmodium
species [24,25,26]. Amino acid repeat-containing proteins encoded
within the Leishmania genomes include several kinases, cysteine
peptidases, putative surface antigen proteins and the infective stage-
specific HASPB (formerly named GBP), expressed in amastigotes of
all L. Leishmania species analysed but absent from L.(Viannia.)
braziliensis [1,27,28,29,30]. HASPB is also a target for N-myristoyla-
tion, a co-translational protein modification catalysed by the
enzymeN-myristoyltransferase (NMT)thatisagenetically-validated
target for Leishmania drug development [31,32].
Hybridisation of these customised oligonucleotide arrays with
amastigote RNA derived from footpad lesions (L. major), spleens (L.
infantum) and RAW 264.7 macrophages (L. braziliensis) revealed
that only a small number of the target genes are differentially
expressed at the mRNA level between species and that fewer still
are regulated during the parasite life cycle. In addition,
comparison of expression profiles derived from L. major amasti-
gotes isolated from hosts of differing immune competence (BALB/
c vs. Rag2
2/2 cc
2/2 mice [33]) demonstrated that host immune
pressure has little effect on parasite gene expression at the RNA
level. Taken as a whole, the data presented here suggest that
parasites do not respond dynamically to host immune pressure and
that any influence of varying transcript levels on virulence and
pathogenicity of different Leishmania species is likely to result from
the differential expression of conserved genes between species
and/or the expression of a small number of genes that are
differentially distributed between species.
Materials and Methods
In silico analyses
The three representative Leishmania proteomes (L .major, L.
braziliensis and L. infantum) were analysed for the presence of amino
acid repeats using default settings at the RepSeq web utility (www.
repseq.org; [22]); 256 proteins were identified. A further 62 proteins
were predicted to be N-terminally myristoylated with high confidence
using the NMT Predictor and Myristoylator programs as described
[23]. The genes identified as differentially distributed between the
three Leishmania species [1] were reanalysed using BLAST and the
latest assemblies of the three genomes available at the time on
GeneDB (L. major published assembly [10], L. infantum v2 and L.
braziliensis v1). 242 of these genes were included in this study (Table
S1); the remainder have been removed during annotation revision.
Leishmania culture, differentiation and in vivo infections
The three sequenced genome reference strains used were L. major
MHOM/IL/80/Friedlin; L. infantum clone JPCM5 MCAN/ES/
Author Summary
The single-celled parasite Leishmania, transmitted by sand
flies in more than 88 tropical and sub-tropical countries
globally, infects man and other mammals, causing a
spectrum of diseases called the leishmaniases. Over 12
million people are currently infected worldwide with 2
million new cases reported each year. The type of
leishmaniasis that develops in the mammalian host is
dependent on the species of infecting parasite and the
immune response to infection (that can be influenced by
host genetic variation). Our research is focused on
identifying parasite factors that contribute to pathogenic-
ity in the host and understanding how these might differ
between parasite species that give rise to the different
clinical forms of leishmaniasis. Molecules of this type might
lead to new therapeutic tools in the longer term. In this
paper, we report a comparative analysis of gene expres-
sion profiles in three Leishmania species that give rise to
different types of disease, focusing on the intracellular
stages that reside in mammalian macrophages. Our results
show that there are only a small number of differences
between these parasite species, with host genetics playing
only a minor role in influencing the parasites’ response to
their intracellular habitat. These small changes may be
significant, however, in determining the clinical outcome
of infection.
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Procyclic and metacyclic parasites were maintained at 26uCi n
pH 7.0 and pH 5.5 media respectively; for L. major and L.
braziliensis,1 6M199 medium was supplemented with 10% Gibco
fetal bovine serum (FBS, Invitrogen) and penicillin-streptomycin
(Invitrogen) and, in the case of L. braziliensis, 2% human male urine.
L. infantum was cultured in Gibco HOMEM (Invitrogen) supple-
mented with 10% FBS (Biosera) and penicillin-streptomycin. The
pH of all media was adjusted using orthophosphoric acid.
Metacyclic RNAs were validated by RT-qPCR profiling of the
metacyclic specific markers SHERP [34] in L. major and L. infantum
and Meta1 [35] in L. braziliensis.F o rL. major in vivo passage, BALB/c
and Rag2
2/2cc
2/2 mice [33,36] were infected sub-cutaneously in
the rear footpad with 4610
6 late stage L. major metacyclics purified
by Percoll gradient fractionation [37]. Footpad thickness was
measured weekly using digital calipers, taking an average of three
readings. At four weeks post-infection, mice were euthanized and
tissues were sampled for analysis. For L. infantum in vivo passage,
infection was initiated in hamsters by intraperitoneal inoculation of
10
7 stationary phase metacyclics as described [38], with euthanasia
and spleen removal 9–12 months later.
BALB/c mice (Charles River Laboratories) and Rag2
2/2cc
2/2
mice (bred in the Centre for Immunology and Infection) were
housed in pathogen-free conditions at the University of York. All
animal work was conducted under UK Home Office Licence
requirements and after institutional ethical review. Attempts to
purify amastigotes from the footpads of BALB/c, C57BL/6 and
Rag2
2/2cc
2/2 mice infected with the L. braziliensis genome strain
were unsuccessful (despite establishment of lymph nodes infections
with the same parasites), so Percoll-purified metacyclics were used
to infect RAW 264.7 macrophages maintained in DMEM
medium supplemented with 10% FBS, l-glutamine and sodium
pyruvate (1 mM final concentrations). Amastigotes were obtained
from infected macrophages after 3 days culture at 34uC. For all
species, infections were initiated with parasites that had been
recently passaged in vivo to reduce any impact of long term in vitro
culture on parasite gene expression and virulence.
Amastigote isolation and protein analysis
Infected tissues were homogenised and fractionated (centrifu-
gation at 100 g, 4uC) to remove larger debris. Host cells in the
resulting supernatant were pelleted (2000 g, 4uC) and treated with
0.05% w/v saponin (Sigma Aldrich) for lysis and release of
amastigotes. Host cell debris was removed by layering parasites
over Percoll (1.037 g/ml) and centrifugation at 2000 g, 4uC for
1 hr. Amastigote yields were assessed using a haemocytometer and
Beckman Z Series Coulter Counter. Parasite species was verified
by restriction fragment length polymorphism analysis of amasti-
gote DNA [39].
For immunoblotting, 5610
6 host-derived amastigotes were
pelleted, washed in PBS and resuspended in an SDS load mix
supplemented with Pepstatin A (50 ug/ml). Treatment with 3% b-
mercaptoethanol was followed by a 10 min incubation at 95uC
prior to 12% SDS-PAGE, electroblotting on immobilon-P
membrane (Millipore) and probing with anti-HASPB [40,41] at
1:1250 dilution and anti-NMT [31] at 1:1000, as previously
described. ECL Western Blotting Detection Reagents (GE
Healthcare Lifesciences) were used in conjunction with a
G:BOX Chemi Imaging System and GeneSnap V.7.0 software
(Syngene) to determine relative expression of detected proteins.
Analysis of parasite burdens
L. major parasite burdens in mouse footpad lesions were
determined by purification and manual counting while those in
the liver and spleen tissues were assessed from duplicate samples
using quantitative PCR, adapted from the method of [42]. DNA
was extracted from tissues using a DNeasy Blood and Tissue kit
(Qiagen) following overnight digestion with Proteinase K at 55uC.
Quantitation of L. major DNA was performed using primers
specific for a 116-bp fragment of the kinetoplastid minicircle DNA:
forward, 59-CCTATTTTACACCAACCCCCAGT-39(JW11) and
reverse, 59-GGGTAGGGGCGTTCTGCGAAA-39 (JW12) [43].
DNA standards were created for each tissue sampled, by
spiking naı ¨ve tissue with known numbers of L. major promastigotes
and extracting the DNA as described above. For RT-qPCR
reactions, samples were analysed using Power SYBR Green PCR
Master Mix and an ABI 7300 sequence analyzer (Applied
Biosystems). Samples were subjected to an initial holding step at
95uC for 10 min, followed by an amplification step (40 cycles of
95uC for 15 sec and 60uC for 1 min) and a single dissociation step
of 95uC for 15 sec, 60uC for 20 sec and 95uC for 15 sec. The total
parasite burden per organ was calculated by determining the total
number of parasites per g of tissue sampled and multiplying by
total organ mass.
RNA isolation, cDNA synthesis and labelling
Amastigote pellets were resuspended in TRIzol Reagent
(Invitrogen) at a concentration of 1 ml/10
8 cells and total RNA
extracted using the protocol provided. Extracted RNA was
purified using a MEGAclear kit (Ambion) and the quantity and
quality verified using a NanoDrop ND-1000 Spectrophotometer
and Agilent 2100 Bioanalyzer, respectively, prior to storage at
280uC. cDNA synthesis and subsequent labelling was performed
using the Amino Allyl cDNA labeling kit (Ambion) and Alexa
Flour 555 and 647 dyes (Invitrogen).
DNA oligonucleotide array design, slide printing,
washing and pre-hybridisation
70-mer oligonucleotides were designed and synthesised by
Operon Biotechnologies using parameters such that a single oligo
had .90% identity with the gene target in each of the three
species but ,70% identity with any other gene on the array. All
oligos (Table S2) were BLAST-searched against the NCBI
databases for the mouse and hamster genomes, to minimise
potential cross hybridisation. The microarrays were printed on
Nexterion Slides E (Schott) using a QArrayMini (Genetix) as
follows: 5 replicates were printed for each probe in a random
pattern totalling 5376 probes per slide (including buffer and
negative controls). cDNA from procyclic RNA from each of the
three species was hybridised against the arrays for quality control,
revealing that all probes were hybridised (data not shown). Prior to
hybridisation, each slide was washed at room temperature as
follows: 165 min in 0.1% Triton X-100, 262 min in 1 mM HCL,
1610 min in 100 mM KCL. Slides were subsequently blocked by
incubation in 16Nexterion Blocking E (Schott) for 15 min and
then dried by centrifugation.
Microarray hybridisation and signal detection
Labelled cDNA pellets were resuspended in Nexterion Hyb and
hybridised on the slides in Corning hybridisation chambers
(Fisher) for 16 hrs at 45uC. The slides were then washed in
26Sodium Chloride Citrate (SSC)/0.1% sodium dodecyl sulphate
(SDS) for 5 min, 26SSC for a further 5 min, 0.26SSC for 5 min
and dried by centrifugation at 200 g for 3 min. The slides were
scanned using an Axon 4000A scanner and fluorescence signal
intensities of the array features and local backgrounds measured
by GenePix Pro 5.0.
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For each slide, flags were automatically assigned to each probe and
manually evaluated, based on the quality of hybridisation, to assist in
normalisationwithinandbetweenarrays.Allrawdataextractedfrom
GenePix were imported into R 2.2.1 for normalization and statistical
analysis using the Bioconductor packages (www.bioconductor.org),
predominantly Limma. Briefly, gpr files were read and background
correction performed using the Kooperberg model. QC analysis,
entailing density distribution analysis coupled with correlation
distance heatmap plotting, was used to identify substandard arrays,
which were removed from further analysis. Array data were
normalised within arrays using printtiploess, followed by normalisa-
tion between arrays using the ‘‘Aquantile’’ method, which normalises
intensity distribution across all slides. Subsequently, the mean
intensity was determined for the 5 replicate spots on each array
prior to single channel linear modelling and contrast fitting of non-
control array features, with eBayes methods to generate moderated t-
statistics. Four contrasts were performed: L. braziliensis procyclics vs.
metacyclics vs. amastigotes, L. major amastigotes vs. procyclics, L.
infantum amastigotes vs. procyclics and L. major amastigotes from
BALB/c mice vs. L. major amastigotes from Rag2
2/2cc
2/2 mice.
Gene lists were generated, with accompanying statistics, from
the eBayes fit data. The decideTests method was applied, with an
adjust p value threshold of 0.01, to classify genes as to their
significance in one of more contrasts. A fold change of 1.7 was
then used as threshold for determining differentially expressed
genes, similar to other recent studies [13,14,20]. In accordance
with MIAME (Minimum Information About a Microarray
Experiments) regulations [44], all data were deposited into
ArrayExpress database [45] at www.ebi.ac.uk under the accession
number E-MEXP-2063.
For host-derived amastigote analysis, a minimum of 3 biological
replicates (each comprising 2–3 technical replicates) per species
were used. 2–3 technical replicates were also used for each of the
following analyses: culture-derived amastigotes, metacyclics and
procyclics
Quantitative real-time PCR (RT-qPCR)
RT-qPCR was performed on selected genes to validate the
microarray data, using 1–2 biological replicates (independent of
those used on the arrays). cDNA was synthesised using the
Omniscript RT Kit (Qiagen) . Cross-species primers were designed
by aligning gene sequences using CLUSTALW (http://align.
genome.jp/) and then selecting primers based on the output of
Primaclade [46]. Each biological sample was run with 4–5 technical
replicates. Data generated were analysed [47] and normalised using
a range of suitable targets (including published controls; [14,35,48]).
All primers used are shown in Table S3.
Results/Discussion
Previous expression profiling studies, using arrays of varying size
and composition, have revealed that the transcriptomes of four L.
Leishmania species (L. major, L. infantum, L. donovani and L mexicana;
[12,13,14,15,49,50,51]) are largely expressed at constitutive levels
during the parasite life cycle, with only a limited number of genes
(,10% of the genome) showing significant evidence of regulation
(fold change .1.7, p,0.05) at the mRNA level. No data have yet
been presented on global expression profiles of any L. Viannia spp,
nor has there been an investigation into the potential influence of
immune pressure on parasite gene expression in the host.
The custom microarrays used in this study targeted 785 genes
representing ,10% of the genome of the 3 target Leishmania
species, L. major, L. infantum and L. braziliensis. Following
hybridisation, a total of 46 genes were selected from the arrays
for validation of their RNA expression profiles by RT-qPCR.
These included a number of previously-characterised stage-
regulated and constitutively-expressed genes across all three
species. In total, 74% (17/23) of the L. braziliensis genes tested
for their expression across the parasite life cycle showed good
correlation between RNA levels detected by RT-qPCR and
microarray analysis (Table 1). A further 8 out of 9 targets from the
cross-species comparison and 12 out of 14 targets selected from the
study of host immune pressure on L. major gene expression were
also validated by comparison of RT-qPCR and microarray data
(Table 1). In most cases, the observed fold changes were
comparable between the microarray and RT-qPCR data although
in some instances, larger differences between the two methods of
analysis were measured. This trend has been reported in similar
studies [12,14] and is likely to be due to the increased sensitivity
and specificity of RT-qPCR against single gene targets.
Only a small number of the genes analysed are regulated
in their expression during the L. braziliensis lifecycle
Expression profiles were generated for eachL. braziliensis life cycle
stage using mRNA from culture-derived procyclics and metacyclics
and RAW 264.7 macrophage-derived amastigotes. The profiles
wereanalysedusingscatterplots(Figure1A–C),revealingthat,9%
(60/678) of the genes probed were significantly regulated (fold
change .1.7, p-value,0.05) in their expression between life cycle
stages. Thus, although the arrays used for this analysis of L.
braziliensis gene expression represent only 10% of the genome (and
are biased towards specific gene subsets), the proportion of stage-
regulated genes (,9%) is of the same order of magnitude as that
observed in whole genome analysis of L. major (7%), L. mexicana
(3.5%) and L. infantum (9.3%) [12,14].
Of the 60 regulated genes in L. braziliensis (Table 2, Figure 2), 5
were preferentially expressed in amastigotes (LbrM05_V2.0380 -
microtubule-associated protein, LbrM07_V2.0360 - ATP-depen-
dent DEAD/H RNA helicase, LbrM09_V2.0960 - calmodulin,
LbrM11_V2.0560 - 40S ribosomal protein S21 and LbrM31_
V2.2570 - 39 nucleotidase/nuclease) with a further 35 preferen-
tially expressed in metacyclics and 11 in procyclics. Analysis of the
specific gene subsets identified none of the NMT targets as
upregulated in amastigotes while 5 of these genes showed
preferential expression in either procyclics and/or metacyclics.
9.8% (25/256) of the genes coding for proteins containing amino
acid repeats showed stage specific regulation, with 3 of these
encoding proteins of unknown function that are preferentially
expressed in the procyclic and metacyclic stages (as compared with
amastigotes). Interestingly, all of the genes preferentially expressed
in L. braziliensis amastigotes in this analysis, with the exception of
the calmodulin array, contain repeat motifs. If these RNA
differences correlate with protein levels, this result could indicate
that repeat-containing proteins are functionally important in the
intracellular stage of the life cycle and provide a useful sub-set of
biomarkers with diagnostic and vaccination potential.
Cross species comparison of amastigote RNA expression
Pair-wise comparisons of amastigote RNA profiles for each of the
three species identified only a small number of conserved genes
showing differential expression. Varying numbers of probes were
directly comparable between the species (as some genes are present
in two rather than three species) including 608 between L. braziliensis
and L. major, 615 between L. braziliensis and L. infantum and 686
between L. major and L. infantum. The expression profiles are shown
in Figure 1D–F, with the number of differentially expressed genes in
each species summarised in Figure 3 (with details in Table S4).
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increased amastigote expression in one species compared with the
other two (Table 3). Five genes were identified as showing
significantly increased expression in L. braziliensis amastigotes: 2
genes with predicted functions (LbrM08_V2.0810 - cathepsin L-like
protease, LbrM25_V2.1020 and LbrM35_V2.3370 - ADP-ribosy-
lation factor) and 3 genes of unknown function (LbrM06_V2.0730,
LbrM20_V2.0550 and LbrM21_V2.0910). A further 5 genes
showed significantly increased expression in L. major amastigotes,
4 of which code for proteins of predicted functions (LmjF06.0400 -
Fructose biphosphate aldolase, LmjF24.1730 - protein kinase,
LmjF31.0830 - Triacyglycerol lipase, LmjF36.5370- tyrosine
specific protein phosphatase) while the last codes for an unknown
protein (LmjF31.1400). A total of 15 genes showed significantly
increased expression in L. infantum amastigotes alone, including 10
coding for proteins of unknown function (LinJ05_V3.0670,
LinJ07_V3.0270, LinJ07_V3.0950, LinJ10_V3.1230,
LinJ13_V3.0770, LinJ14_V3.0470, LinJ18_V3.1160, LinJ24_V3.1530,
LinJ29_V3.0110 and LinJ31_V3.1470). and 5 for proteins of
predicted function (LinJ12_v4.0671 – surface antigen protein,
LinJ04_V3.0320 - mitochondrial exoribonuclease DSS-1,
LinJ11_V3.0400 - tubulin-tyrosine ligase-like protein,
LinJ31_V3.1490 - surface membrane protein gp46-like protein
and the proteophosphoglycan ppg3 array on chromosome 35
(chromosome 34 in L. braziliensis). Interestingly, gp46 has also
been identified as an upregulated gene in L. donovani amastigotes
derived from patients with PKDL (post-kala azar dermal
leishmaniasis; [52]).
The ppg3 gene is located within an array of related sequences (still
undergoing refinement of annotation due to their repetitive structure)
on chromosome 35 of Leishmania species and codes for one of the
glycoprotein constituents of filamentous proteophosphoglycan
(fPPG), a major component of promastigote secretory gel (PSG).
PSG is produced by parasites within the gut of the sandfly vector,
where it contributes to a physical blockage that promotes host blood-
feeding and subsequent parasite transmission [53,54]. The Leishmania
PPGs belong to a novel class of serine- and threonine-rich proteins
possessing large conserved Ala-Pro-Ser repeats that represent major
antigenic determinants in all Leishmania species examined to date
[53,55,56]. These repeats are extensively modified by phosphodie-
ster-linked oligosaccharides and terminal manno-oligosaccharides,
while the modified PPGs are either water soluble and secreted or
membrane-bound. PPGs are expressed in both promastigotes and
amastigotes, localising to the flagellar pocket, endosomes, lysosomes
and the external surface of the parasite [57,58,59]. Surface PPGs are
important in parasite-macrophage interactions: they apparently bind
Table 1. Validation of microarray data by quantitative RT-PCR (RT-qPCR).
L. braziliensis lifecycle L. braziliensis vs L. infantum amastigotes
GeneDB ID Array LogFC RT-qPCR LogFC L. braziliensis ID L. infantum ID Array LogFC RT-qPCR LogFC
LbrM04_V2.0370 2.78 21.45* LbrM03_V2.0240 LinJ03_V3.0220 25.82 20.83
LbrM07_V2.0360 21.11 21.22 LbrM08_V2.0810 LinJ08_V3.0960 2.22 5.34
LbrM09_V2.0960 21.04 22.94 LbrM16_V2.0920 LinJ16_V30920 2.53 291.62
LbrM11_V2.0560 22.80 21.63
LbrM12_V2.0750 22.31 20.84 L. major vs L. infantum
LbrM21_V2.0360 2.51 0.55* L. major ID L. infantum ID Array LogFC RT-qPCR LogFC
LbrM26_V2.0120 0.84 1.64 LmjF03.0230 LinJ03_V3.0220 25.29 210.43
LbrM31_V2.2570 20.89 22.90 LmjF13.0880 LinJ13_V3.0770 22.68 22.66
LbrM31_V2.3150 1.91 21.09* LmjF29.1480 LinJ29_V3.1580 0.01 9.49*
LbrM34_V2.4130 23.15 22.71 LmjF31.3000 LinJ31_V3.3110 21.83 21.87
LbrM08_V2.0810 1.95 20.57* LmjF32.1950 LinJ32_V3.2060 0.01 1.21
LbrM09_V2.0840 1.19 2.54 LmjF36.4310 LinJ36_V3.4520 2.88 0.28
LbrM09_V2.0960 20.82 20.46
LbrM11_V2.0560 22.51 20.18 L. major amastigotes from BALB/c and Rag2
2/2cc
2/2 mice
LbrM20_V2.0550 2.48 1.01 L. major ID Array LogFC RT-qPCR LogFC
LbrM31_V2.3150 2.08 21.84* LmjF03.0230 0.50 0.05
LbrM04_V2.0370 23.67 2.55* LmjF04.0210 20.17 0.44*
LbrM08_V2.0810 1.67 1.09 LmjF24.0220 20.25 20.12
LbrM12_V2.0750 3.08 4.16 LmjF24.1840 1.35 0.43
LbrM18_V2.0050 1.62 21.07* LmjF25.1820 20.03 20.18
LbrM20_V2.0550 2.46 1.99
LbrM32_V2.2500 0.79 3.66
LbrM34_V2.4130 3.47 1.41
*RT-qPCR data does not validate microarray data; LogFC represents 2log2(fold change); ID, each ID refers to the GeneDB gene entry.
doi:10.1371/journal.pntd.0000476.t001
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distribution of log2 fold changes in RNA expression levels against their statistical significance (2log2 p-value) for up to 785 genes per genome. Fold
change of .1.7 between data points (dashed horizontal lines); significant p-value,0.05 (dashed vertical lines). (A) L. braziliensis amastigotes vs.
procyclics; (B) L. braziliensis amastigotes vs. metacyclics; (C) L. braziliensis metacyclics vs. procyclics; amastigotes of (D) L. braziliensis vs. L. major, (E) L.
braziliensis vs. L. infantum, (F) L. major vs. L. infantum; (G) L. major amastigotes from BALB/c vs. Rag2
2/2cc
2/2 mice.
doi:10.1371/journal.pntd.0000476.g001
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L. braziliensis: Amastigotes vs. Procyclics
GeneDB ID Product LogFC P value Note Up in
LbrM34_V2.4130 Poly A binding protein 23.15 0.0197 SRR* Amastigote
40S ribosomal protein S21 22.80 0.0359 SRR* Amastigote
LbrM12_V2.0750 Surface antigen proteins (1 and 2) 22.31 0.0008 SRR* Amastigote
LbrM07_V2.0360 ATP-dependent DEAD/H RNA helicase 21.11 0.0405 SRR* Amastigote
LbrM09_V2.0960/LbrM09_V2.0970/
LbrM09_V2.0980
Calmodulin 21.04 0.0274 * Amastigote
LbrM31_V2.2570
1 39 nucleotidase/nuclease 20.89 0.0272 * Amastigote
LbrM26_V2.0120 Adenine phosphoribosyltransferase 0.84 0.0050 * Procyclic
LbrM22_V2.1410
1 Unknown function 0.86 0.0398 Procyclic
LbrM27_V2.1350
1 Carboxypeptidase 0.99 0.0172 Procyclic
LbrM33_V2.0190 Unknown function 1.08 0.0397 Procyclic
LbrM11_V2.0160 Unknown function 1.08 0.0163 Procyclic
LbrM20_V2.4280 Unknown function 1.11 0.0062 Procyclic
LbrM12_V2.0750 Surface antigen proteins (1 and 2) 1.20 0.0006 SRR Procyclic
LbrM34_V2.0500 Unknown function 1.84 0.0000 Procyclic
LbrM31_V2.3150 Adp-ribosylation factor 1.91 0.0073 NMT* Procyclic
LbrM21_V2.0360 Unknown function 2.51 0.0126 NMT* Procyclic
LbrM04_V2.0370 Adp-ribosylation factor 2.78 0.0425 NMT* Procyclic
LbrM30_V2.1290 Unknown function 3.98 0.0008 Procyclic
LbrM31_V2.0450 Unknown function 4.25 0.0035 Procyclic
L. braziliensis: Amastigotes vs. Metacyclics
GeneDB ID Product LogFC P value Note Up in
LbrM11_V2.0560 40S ribosomal protein S21 22.51 0.0034 SRR* Amastigote
LbrM12_V2.0750
11 Surface antigen proteins (1 and 2) 22.08 0.0215 SRR Amastigote
LbrM05_V2.0380 Microtubule-associated protein 21.11 0.0454 Amastigote
LbrM09_V2.0960/LbrM09_V2.0970/
LbrM09_V2.0980
Calmodulin 20.82 0.0063 * Amastigote
LbrM34_V2.0360 Serine palmitoyltransferase 0.82 0.0184 Metacyclic
LbrM04_V2.1260 Surface antigen-like protein 0.86 0.0252 SRR Metacyclic
LbrM27_V2.1350
1 Carboxypeptidase 0.86 0.0014 Metacyclic
LbrM33_V2.0190 Unknown function 0.90 0.0071 Metacyclic
LbrM19_V2.1010 Kinesin 0.91 0.0001 SRR Metacyclic
LbrM35_V2.5860 G-actin binding protein 0.91 0.0269 Metacyclic
LbrM11_V2.0160 Unknown function 0.96 0.0010 Metacyclic
LbrM08_V2.1090/LbrM08_V2.1080/
LbrM08_V2.1100
Amastin-like protein 0.98 0.0033 Metacyclic
LbrM34_V2.5330 Unknown function 0.99 0.0107 Metacyclic
LbrM07_V2.0890 Unknown function 1.11 0.0253 Metacyclic
LbrM20_V2.4280 Unknown function 1.11 0.0000 Metacyclic
LbrM33_V2.1190 Unknown function 1.17 0.0037 Metacyclic
LbrM24_V2.1790 Protein kinase 1.18 0.0068 NMT Metacyclic
LbrM04_V2.0590 Unknown function 1.18 0.0075 Metacyclic
LbrM09_V2.0840 Unknown function 1.19 0.0005 SRR* Metacyclic
LbrM06_V2.0760 RNA-binding protein-like pr 1.20 0.0016 SRR Metacyclic
LbrM25_V2.0950 Unknown function 1.28 0.0035 SRR Metacyclic
LbrM22_V2.1410
1 Unknown function 1.30 0.0000 Metacyclic
LbrM07_V2.0550 Unknown function 1.30 0.0006 Metacyclic
LbrM28_V2.3180
1 Unknown function 1.32 0.0224 Metacyclic
LbrM32_V2.1080 Unknown function 1.39 0.0250 Metacyclic
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GeneDB ID Product LogFC P value Note Up in
LbrM24_V2.0360/LbrM24_V2.0440 CMP-sialic acid transporter 1.40 0.0291 Metacyclic
LbrM33_V2.3400 Unknown function 1.44 0.0252 Metacyclic
LbrM23_V2.0100 Unknown function 1.50 0.0472 SRR Metacyclic
LbrM31_V2.3260 Nucleoporin (NUP54/57) 1.50 0.0266 SRR Metacyclic
LbrM04_V2.0550 Unknown function 1.53 0.0434 SRR Metacyclic
LbrM15_V2.0460/LbrM15_V2.0470/
LbrM15_V2.0480
Unknown function 1.55 0.0119 Metacyclic
LbrM04_V2.0470
1 Unknown function 1.70 0.0090 Metacyclic
LbrM21_V2.2150/LbrM33_V2.0920/
LbrM33_V2.0930/LbrM33_V2.0960
Beta-tubulin 1.71 0.0059 Metacyclic
LbrM18_V2.0050
1 Transporter (sugar) 1.95 0.0004 Metacyclic
LbrM08_V2.0810/LbrM08_V2.0820/
LbrM08_V2.0830
Cathepsin L-like protease 1.95 0.0001 * Metacyclic
LbrM27_V2.2760 Peptidyl dipeptidase 1.97 0.0211 Metacyclic
LbrM30_V2.1290 Unknown function 2.03 0.0044 Metacyclic
LbrM31_V2.3150 Adp-ribosylation factor 2.08 0.0000 NMT* Metacyclic
LbrM34_V2.0500 Unknown function 2.15 0.0000 Metacyclic
LbrM21_V2.0360 Unknown function 2.25 0.0006 NMT Metacyclic
LbrM30_V2.2320 Adp-ribosylation factor-like protein 2.28 0.0113 Metacyclic
LbrM20_V2.0550 Unknown function 2.48 0.0079 SRR* Metacyclic
L. braziliensis: Procyclics vs Metacyclics
GeneDB ID Product LogFC P value Note Up in
LbrM04_V2.0370 Adp-ribosylation factor 23.67 0.0016 NMT Procyclic
LbrM16_V2.0790 Unknown function 23.08 0.0061 Procyclic
LbrM31_V2.0450 Unknown function 23.08 0.0078 Procyclic
LbrM05_V2.0960 Unknown function 22.77 0.0171 Procyclic
LbrM31_V2.1250 Unknown function 22.50 0.0223 SRR Procyclic
LbrM15_V2.0940 Unknown function 22.42 0.0180 SRR Procyclic
LbrM34_V2.0010/LbrM34_V2.0040/
LbrM34_V2.0060
Pyruvate kinase 22.35 0.0444 Procyclic
LbrM32_V2.3450 Unknown function 22.17 0.0356 Procyclic
LbrM30_V2.1290 Unknown function 21.95 0.0304 Procyclic
LbrM07_V2.0950 Unknown function 21.91 0.0389 Procyclic
LbrM32_V2.2500 Membrane associated protein-like protein 0.79 0.0223 SRR Metacyclic
LbrM19_V2.1010 Kinesin 0.83 0.0039 SRR Metacyclic
LbrM29_V2.0470 Unknown function 1.31 0.0383 SRR Metacyclic
LbrM18_V2.1250 Unknown function 1.55 0.0306 NMT Metacyclic
LbrM18_V2.0050
1 Transporter (sugar) 1.62 0.0169 Metacyclic
LbrM08_V2.0810/LbrM08_V2.0820/
LbrM08_V2.0830
Cathepsin L-like protease 1.67 0.0064 Metacyclic
LbrM20_V2.1060 Amastin-like surface protein 2.02 0.0257 Metacyclic
LbrM20_V2.0610 Unknown function 2.05 0.0134 SSR Metacyclic
LbrM30_V2.2950 Glyceraldehyde 3-phosphate dehydrogenase 2.12 0.0359 Metacyclic
LbrM20_V2.0550 Unknown function 2.46 0.0378 SRR Metacyclic
LbrM12_V2.0750 Surface antigen proteins (1 and 2) 3.08 0.0000 SRR Metacyclic
LbrM34_V2.4130 Poly A binding protein 3.47 0.0021 SRR Metacyclic
GeneDB ID, gene accession number on GeneDB (http://www.genedb.org/); Product, predicted gene function (annotation from GeneDB); LogFC,l o g 2 fold change
observed between compared RNAs in array studies; P value, measure of statistical significance (p,0.05 is statistically significant); Note, indicates whether gene is from
a specific subset (SSR – amino acid repeat containing gene, NMT – target for N-myristoylation); * indicates where array data are validated by qPCR (see Table 4); Up in,
indicates species or lifecycle stage with increased expression of target gene.
1annotated as a pseudogene in GeneDB.
doi:10.1371/journal.pntd.0000476.t002
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both by inhibiting tumor necrosis factor-a production and synergiz-
ing with interferon-c to stimulate the production of nitric oxide [60].
T h es i g n i f i c a n c eo fi n c r e a s e dR N Ae x p r e s s i o nf r o mt h eP P Gg e n e
array in L. infantum amastigotes (as compared with L. major and L.
braziliensis amastigotes) is unknown; no studies have yet investigated
the L. infantum PPGs or addressed whether one or more of these
molecules might perform a species-specific role in establishing and
maintaining amastigotes within host macrophages.
Calmodulin, the ubiquitous eukaryotic intracellular calcium
receptor, plays a role in the regulation of many cellular proteins
and transmembrane ion transporters with wide-ranging down-
stream physiological consequences. Calmodulin is encoded by a 3-
gene array on chromosome 9 in Leishmania but has not yet been
widely studied in this organism, despite linkage to the modulation of
a plasmamembraneCa
2+-ATPaseinL. donovani [61]. Inthis present
study, both the array analyses and subsequent RT-qPCRs show
decreased abundance of calmodulin transcripts in amastigotes of L.
major and L. infantum as compared with procyclic and metacyclic
parasites. This correlates with the observed changes in calmodulin
protein during in vitro differentiation of L. donovani [62]. By contrast,
calmodulin transcript levels are upregulated in L. braziliensis
amastigotes (Figure 4). To date, it is unclear whether these RNA
differences reflect mRNAs derived from one or several of the gene
copies,norhowthisdistributionmightvarybetweenthespecies.Itis
also unknown whether the varying RNA levels correlate with
protein expression in L. braziliensis and how this might influence
calmodulin function in different amastigote populations.
Genes differentially distributed between the three
representative Leishmania species are usually
constitutively expressed
The small number of differentially distributed genes identified
by comparative genomic analysis of L. major, L. infantum and L.
braziliensis [1] include several well-characterised stage specific
genes that are implicated in vector transmission and virulence in
the host (e.g. A2, HASPB, SHERP [11,34,63]. The expression
profiles for the ,200 differentially distributed genes were
determined from the L. braziliensis life cycle analysis generated
here and supplemented with published microarray data generated
from life cycle studies of L. major and L. infantum [12,14] (Table S1).
These cumulative results have confirmed that all genes differen-
tially distributed between the three species are expressed in all life
cycle stages. Only 34 of these sequences are regulated between
stages, however: 19 in L. major,9i nL. infantum and 6 in L.
braziliensis. The majority of these genes encode proteins of
unknown function while the remainder are the HASPA, HASPB
and SHERP genes from L. Leishmania species as well as an adenine
phosphoribosyltransferase (LbrM26_V2.0120) and a unique gene
family in L. braziliensis (LbrM23_V2.1110 and LbrM23_V2.1120)
and the L. infantum specific LinJ22_V3.0670.
Leishmaniatranscriptomesundergolittleregulationbutthe
conserved genes that are regulated vary between species
Previous comparisons of the life cycle expression profiles of L.
major, L. infantum and L. mexicana have revealed similar numbers of
Figure 3. Differential expression of amastigote genes between
Leishmania species. Venn diagrams showing pairwise comparisons of
amastigote RNA expression from the three target Leishmania species;
the number of genes with increased expression (.1.7-fold, p,0.05) in
each species is indicated. *Genes that show no significant difference in
expression between species.
doi:10.1371/journal.pntd.0000476.g003
Figure 2. Distribution of genes preferentially expressed in one
or more stages of L. braziliensis. Venn diagram showing distribution
of upregulated genes (.1.7 fold, p,0.05) in stages of the L. braziliensis
life cycle. 8.8% (60/678) of the genes probed are regulated in their
expression by these criteria, with 58% of these showing increased
expression during the metacyclic stage. *Genes that are not differen-
tially expressed between these stages.
doi:10.1371/journal.pntd.0000476.g002
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interesting observation associated with these data is that, while
these regulated genes are conserved between all three species,
whether they are regulated or not appears to be a species-specific
property. As an example of this, only 114/1228 of the conserved
regulated genes of L. major and L. infantum undergo modulation in
both species [14]. A similar effect has been observed in
comparisons between L. major and L. mexicana promastigote RNA
expression profiles [12]. In this current study, of the 21 genes
identified as being stage regulated in L. braziliensis (Table S5), 14
are only regulated in this species while 6 share regulation with
either L. major or L. infantum and one, a 39-nucleotidase/nuclease, is
regulated in all three species and shows upregulation in
amastigotes [12,14]. Leishmania parasites are purine auxotrophs
andrequire mechanismstosalvagetheseessentialnutrientsfrom the
sandfly gut and the host [64,65,66]. The 39-nucleotidase/nuclease
[67] degrades and dephosphorylates exogenous purine sources to
nucleosides that can be transported across the plasma membrane
[67]. Independent studies in L. donovani [68] and L. mexicana [69]
have shown that 39-nucleotidase/nuclease mRNA transcripts are
upregulated in promastigotes when parasites are starved of purines
but not in amastigotes. One interpretation of these conflicting
observations could be that there are additional gene copies
expressing nucleotidase/nuclease activity during the parasite life
cycle. The complete list of all regulated genes identified in L.
braziliensis, L. major and L. infantum is presented in Table S5.
Table 3. Conserved genes preferentially expressed in amastigotes.
Genes preferentially expressed in L. braziliensis amastigotes
L. major ID L. infantum ID L. braziliensis ID Product LogFC (Lb vs. Lm) LogFC (Lb vs. Li)
LmjF34.0620 LinJ34_V3.0640 LbrM20_V2.0550 Unknown function 2.12 2.33
LmjF08.1020 LinJ08_V3.0960 LbrM08_V2.0810 Cathepsin L-like protease 1.58 1.49
LmjF06.0740 LinJ06_V3.0770 LbrM06_V2.0730 Unknown function 1.00 1.45
LmjF36.3150 LinJ36_V3.3300 LbrM35_V2.3370 Adp-ribosylation factor GTPase
activating protein
0.98 0.79
LmjF21.0820 LinJ21_V3.0900 LbrM21_V2.0910 Unknown function 0.92 0.95
Genes preferentially expressed in L. infantum amastigotes
L. major ID L. infantum ID L. braziliensis ID Product LogFC (Li vs. Lb) LogFC (Li vs. Lm)
LmjF03.0230 LinJ03_V3.0220 LbrM03_V2.0240 Long chain fatty Acyl CoA synthetase 2.41 2.30
LmjF04.0330 LinJ04_V3.0320 LbrM04_V2.0360 Mitochondrial exoribonuclease DSS-1 1.19 1.99
LmjF05.0670 LinJ05_V3.0670 LbrM05_V2.0660 Unknown function 2.46 2.34
LmjF07.0120 LinJ07_V3.0270 LbrM07_V2.0120 Unknown function 1.74 1.55
LmjF07.0840 LinJ07_V3.0950 LbrM07_V2.0890 Unknown function 2.21 0.80
LmjF10.1140 LinJ10_V3.1230 LbrM10_V2.1250 Unknown function 2.10 2.73
LmjF11.0400 LinJ11_V3.0400 LbrM11_V2.0080 Tubulin-tyrosine ligase-like protein 1.11 1.01
LmjF13.0880 LinJ13_V3.0770 LbrM13_V2.0690 Unknown function 1.82 1.64
LmjF14.0470
1 LinJ14_V3.0470 LbrM14_V2.0480 Unknown function 0.85 0.86
LmjF18.1150 LinJ18_V3.1160 LbrM18_V2.1250 Unknown function 1.27 0.77
LmjF22.1680
1 LinJ22_V3.1530 LbrM22_V2.1590
1 Phosphoinositide-specific
phosphatase C
0.98 0.86
LmjF24.1470 LinJ24_V3.1530 LbrM24_V2.1380 Unknown function 2.58 2.70
LmjF29.0110 LinJ29_V3.0110 LbrM29_V2.0120 Unknown function 1.27 0.95
LmjF31.1440 LinJ31_V3.1470 LbrM31_V2.1670 Unknown function 1.30 1.26
LmjF31.1440 LinJ31_V3.1470 LbrM31_V2.1670 Unknown function 2.13 2.52
LmjF35.0520 LinJ35_V3.0530 LbrM34_V2.0520 Proteophosphoglycan ppg3, putative 1.53 1.24
Genes preferentially expressed in L. major amastigotes
L. major ID L. infantum ID L. braziliensis ID Product LogFC (Lm vs. Lb) LogFC (Lm vs. Li)
LmjF06.0400
1 LinJ06.0400
1 LbrM06_V2.0380
1 Fructose biphosphate aldolase 1.08 0.81
LmjF24.1730 LinJ24_V3.1800 LbrM24_V2.1790 Protein kinase, putative 1.15 1.15
LmjF31.0830 LinJ31_V3.0860 LbrM31_V2.1010
1 Triacyglycerol lipase 0.78 0.79
LmjF31.1400 LinJ31_V3.1430 LbrM31_V2.1560 Unknown function 1.44 0.80
LmjF36.5370 LinJ36_V3.5610 LbrM35_V2.5630 Tyrosine specific protein phosphatase 1.50 0.77
ID, gene accession number on GeneDB (http://www.genedb.org/); Product, predicted gene function (GeneDB annotation); LogFC,l o g 2 fold change observed
between compared RNAs in array studies. Lb, L. braziliensis;L m ,L. major; Li, L. infantum.
1annotated as pseudogene.
doi:10.1371/journal.pntd.0000476.t003
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and survival in the viscera but does not influence parasite
RNA expression profiles
The influence of host immune pressure on gene expression in
Leishmania has not been studied in vivo to our knowledge. In this
study, parasite burdens, lesion development, and parasite gene
expression profiles were examined in immunocompetent BALB/c
and immunocompromised Rag2
2/2cc
2/2 mice which have a
mixed genetic background of129 Ola, BALB/c and C57BL/6 [33].
These latter mice possess a mutation in the common c-chain
receptor (a component of the receptors for IL-2, -4, -7, -9 and -15)
and in the recombination activating gene 2 (Rag2; required for
V(J)D rearrangement) and are characterised by a complete absence
of mature T lymphocytes, B lymphocytes and NK cells [33].
Footpad infections were established by inoculation with 4610
6
metacyclic L. major parasites and resultant lesion formation was
measured at weekly intervals. The Rag2
2/2cc
2/2 mice displayed
no signs of inflammation in the footpad and did not develop
cutaneous lesions. In contrast, vigorous lesion development was
seen in BALB/c mice with a greater than 2-fold increase in
footpad thickness at one month post-infection (Figure 5A). Parasite
burdens in the footpads of Rag2
2/2cc
2/2 mice were significantly
Figure 4. Calmodulin RNA expression is upregulated in
amastigotes of L. braziliensis. Comparison of amastigote RNA levels
by both microarray and RT-qPCR analysis demonstrates increased
expression from the chromosome 9 calmodulin gene array in L.
braziliensis but decreased expression in L. major and L. infantum.2
independent biological replicates were used to generate data from
each species.
doi:10.1371/journal.pntd.0000476.g004
Figure 5. Comparison of L. major infections in BALB/c and Rag2
2/2cc
2/2 mice. Groups of 5 mice of each strain were inoculated with L. major
purified metacyclics and infections monitored over a 4 week period as described (Materials and Methods). (A) Lesion development (footpad
thickness); (B) parasite burdens in footpad lesions after 4 weeks; (C) parasite burdens in spleen after 4 weeks; (D) parasite burdens in liver after 4
weeks. The data presented are representative of two independent studies; error bars represent the standard error of the mean and the * indicates a
significant difference (p,0.05) as determined by Students t-test (unpaired).
doi:10.1371/journal.pntd.0000476.g005
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mised mice showed 2.5-fold higher parasite burdens in the liver
and spleen (Figure 5B–D). Enhanced parasite burdens in visceral
organs may arise from accelerated dissemination of parasites
through the lymphatic system from the site of infection, as Rag2
2/
2cc
2/2 mice lack peripheral lymph nodes. In addition, survival
and proliferation of parasites may be increased in these tissues due
to the inability of Rag2
2/2cc
2/2 mice to mount protective T and
B cell dependant responses required for parasite clearance.
Expression profiling of the amastigotes taken from the footpads
of these mouse strains revealed only 3 genes that showed a
significant difference in expression (out of 700 genes on the array).
Only one of these genes (LmjF06.0720, coding for a protein of
unknown function) was preferentially expressed in amastigotes
from BALB/c mice. The other 2 genes showed increased
expression in the Rag2
2/2cc
2/2 mice: LmjF24.1840, a lysopho-
spholipase and LmjF35.4730, another ‘‘unknown’’ gene (Table 4).
Independent analysis of HASPB transcript and protein abundance
in these amastigotes (by RT-qPCR and immunoblotting respec-
tively) revealed no significant differences in expression (Figure 6).
This lack of amastigote RNA modulation, assuming that it
correlates with protein expression levels, confirms that Leishmania
parasites are pre-adapted toward intracellular survival, regardless
of the state of the host immune system. These data are of relevance
to our interpretation of the cross-species amastigote expression
results (Table 3) given that the amastigotes were sourced from
rodents of different genetic backgrounds.
Concluding remarks
Small microarrays, targeted towards 9% of the genes conserved
between the three representative Leishmania species and an
additional ,250 genes differentially distributed between these
species, were designed and hybridised with host-derived amasti-
gote RNA isolated from cutaneous lesions (L. major), spleens (L.
infantum) and RAW 264.7 macrophages (L. braziliensis). ,9% of the
probed genes were identified as being regulated during the L.
braziliensis life cycle, a figure comparable to that observed using
whole genome arrays for L. major, L. mexicana and L. infantum
[12,14]. It is interesting to note however, that while most regulated
genes are conserved between all three representative species, the
majority of genes regulated in one species are not regulated in the
others. Moreover, comparative expression profiles generated for L.
major, L. infantum and L. braziliensis amastigotes revealed that
species-specific differential regulation of conserved genes was
common and this may impact on parasite survival in the host.
These species-specific differences require further study that should
focus on determining whether relative protein abundances are
affected by increased transcript abundances. Attempts to correlate
Table 4. Genes differentially expressed in L. major amastigotes from different host genetic backgrounds.
GeneDB ID Product LogFC P.Value Note Up in
LmjF06.0720 Unknown function 20.95 0.0091 SRR* Balb/c amastigotes
LmjF24.1840 Lysophospholipase 1.35 0.0000 * Rag2
2/2cc
2/2 amastigotes
LmjF35.4730
1 Unknown function 0.82 0.0003 * Rag2
2/2cc
2/2 amastigotes
GeneDB ID, gene accession number on GeneDB (http://www.genedb.org/); Product, predicted gene function (annotation from GeneDB); LogFC,l o g 2 fold change
observed between compared RNAs in array studies; P value, measure of statistical significance; Note, indicates whether gene is from a specific subset (SSR – amino
acid repeat containing gene, NMT – target for N-myristoylation); *indicates where array data are validated by qPCR (see Table 4); Up in, indicates host with increased
expression of target gene.
1annotated as a pseudogene in GeneDB.
doi:10.1371/journal.pntd.0000476.t004
Figure 6. HASPB RNA and protein abundance in L. major amastigotes isolated from BALB/c and Rag2
2/2cc
2/2 mice. Amastigotes
isolated from the livers of two mice of each strain (BALB/c and Rag2
2/2cc
2/2 mice), 4 weeks post-infection with L. major (see Figure 5), were used for
RNA and protein extraction, as described. HASPB expression was analysed by (A) RT-qPCR for RNA and (B) immunoblotting with anti-HASPB for
protein (L. major HASPB migrates at 38.5 kDa (black arrow); NMT, at 50 kDa (white arrow)). NMT was used as a constitutive control for both RNA and
protein expression levels.
doi:10.1371/journal.pntd.0000476.g006
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www.plosntds.org 12 July 2009 | Volume 3 | Issue 7 | e476the relative abundance of mRNA and protein for individual genes
in L. infantum amastigotes resulted in only modest agreement
(,53% [21]), with these differences attributed to the extensive
post-transcriptional, translational and post-translational regulation
operating in Leishmania parasites [13,21]. Finally, the lack of
modulation of gene expression profiles in L. major parasites
responding to different immune pressures is consistent with the
hypothesis that Leishmania parasites are constitutively adapted
toward survival in a range of hosts [20].
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